Palvella Therapeutics (PVLA) Equity Ratio (2016 - 2024)
Historic Equity Ratio for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to 4.26.
- Palvella Therapeutics' Equity Ratio fell 92885.84% to 4.26 in Q3 2024 from the same period last year, while for Sep 2024 it was 4.26, marking a year-over-year decrease of 92885.84%. This contributed to the annual value of 9.87 for FY2023, which is 347386.56% down from last year.
- As of Q3 2024, Palvella Therapeutics' Equity Ratio stood at 4.26, which was down 92885.84% from 3.23 recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Equity Ratio ranged from a high of 0.51 in Q3 2023 and a low of 9.87 during Q4 2023
- For the 5-year period, Palvella Therapeutics' Equity Ratio averaged around 0.77, with its median value being 0.33 (2021).
- Per our database at Business Quant, Palvella Therapeutics' Equity Ratio soared by 16608.1% in 2020 and then tumbled by 347386.56% in 2023.
- Quarter analysis of 5 years shows Palvella Therapeutics' Equity Ratio stood at 0.3 in 2020, then increased by 11.86% to 0.33 in 2021, then dropped by 11.51% to 0.29 in 2022, then crashed by 3473.87% to 9.87 in 2023, then skyrocketed by 56.84% to 4.26 in 2024.
- Its Equity Ratio was 4.26 in Q3 2024, compared to 3.23 in Q2 2024 and 2.61 in Q1 2024.